COPD Clinical Trial
Official title:
Feasibility of a Post-Hospitalization PT Intervention in Patients With Pneumonia
Verified date | August 2019 |
Source | The University of Texas Medical Branch, Galveston |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The original intent was to use a manual therapy and therapeutic exercise intervention with older patients with pneumonia post-hospitalization. It was hypothesized that the physical therapy intervention would have a positive impact on posture, physical function, pulmonary function, gait, quality of life, and ultimately readmission. This patient population was found to be not feasible to recruit and the study target population was expanded to include older community dwelling adults with pneumonia, chronic obstructive pulmonary disease (COPD), or hyperkyphosis.
Status | Completed |
Enrollment | 24 |
Est. completion date | December 20, 2019 |
Est. primary completion date | April 18, 2019 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 50 Years and older |
Eligibility |
Inclusion Criteria: - at least 50 years of age - hyperkyphosis, forward head posture, pneumonia, or chronic obstructive pulmonary disease (COPD) - community dwelling - self report of ability to walk 10 feet or greater with or without an assistive device - ability to perform informed consent - ability to transport to research facility - ability to read and write in English or Spanish Exclusion Criteria: - Inability to perform informed consent - Inability to follow directions - Inability to perform transfers, sit, and stand independently - Inability to ambulate 10 feet or more with or without an assistive device - Inability to perform pulmonary function testing - Inability to fully participate in testing and measures - Inability to fully participate in the intervention - Severe claustrophobia - Unable to tolerate physical touch - Morbid obesity (BMI greater than 40) - History of prior lung disease such as cancer or transplant - History of comorbidity that would affect lung function such as neuromuscular disease (ALS, MS), collagen disease (SLE), cardiovascular disease (CHF), or musculoskeletal disease with an autoimmune component (Ankylosing Spondylosis, RA). - A prior discharge within 30 days of hospitalization for pneumonia or COPD - Discharge against medical advice |
Country | Name | City | State |
---|---|---|---|
United States | School of Health Professions at the University of Texas Medical Branch | Galveston | Texas |
Lead Sponsor | Collaborator |
---|---|
The University of Texas Medical Branch, Galveston |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Weight | measured in pounds | through study completion (4 weeks) and one time follow-up at an average of 6 months | |
Primary | Posture, as measured by change in height | Height in cm | through study completion (4 weeks) and one time follow-up at an average of 6 months | |
Primary | Posture, as measured by change in kyphotic index | kyphotic index = (thoracic width/thoracic height) *100 as measured from flexicurve tracing. A flexible ruler is molded to the posterior spine from C7 to the lumbosacral interspace. Ruler is placed on paper and traced. Measures of the thoracic width and height are taken in centimeters. | through study completion (4 weeks) and one time follow-up at an average of 6 months | |
Primary | Posture, as measured by change in block test | height of blocks (measured in cm) under the head with participant supine | through study completion (4 weeks) and one time follow-up at an average of 6 months | |
Primary | Posture, visual change in digital photos | Digital photo in standing anterior and side views as well as supine view | through study completion (4 weeks) and one time follow-up at an average of 6 months | |
Secondary | Function as a change in Timed Up and Go speed | Timed Up and Go as measured in seconds to performed standardized functional test. Participants are timed in seconds from sitting in a chair to standing, walking 3 meters, turning around, walking back, and sitting down. | through study completion (4 weeks) and one time follow-up at an average of 6 months | |
Secondary | Function as a change in Functional Reach test | Functional reach as measured in cm. It is performed by having the participant standing still and is instructed to reach forward as far as you can without taking a step. | through study completion (4 weeks) and one time follow-up at an average of 6 months | |
Secondary | Function as a change in the Short Physical Performance Battery (SPPB) score | SPPB score as determined by seconds to perform each component of this standardized test. This functional test has 3 components of 5 times sit to stand, gait speed, and balance. 5 times sit to stand is a standardized test of lower extremity strength that is performed by rising and sitting in a chair 5 times in a row. The activity is timed. Gait speed will be extracted from gaitrite data. Balance tests will be timed. | through study completion (4 weeks) and one time follow-up at an average of 6 months | |
Secondary | Function and Gait as a change in the 2 Minute Walk Test (2MWT) | 2MWT is the measured as the distance (feet) covered in 2 minutes | through study completion (4 weeks) and one time follow-up at an average of 6 months | |
Secondary | Function and patient perception as change in the Patient Specific Functional Scale (PSFS) | PSFS is a standardized survey of activities that are difficult to perform (listed by participant) and to what degree as measured on a likert scale (0 to 10) | through study completion (4 weeks) and one time follow-up at an average of 6 months | |
Secondary | Gait as measured by change in gait parameters on a Gaitrite walkway | The gaitrite records a standard set of parameters. Change in gait speed (m/sec), step length (cm), stride length (cm), double limb support time (seconds), and step width (cm) | through study completion (4 weeks) and one time follow-up at an average of 6 months | |
Secondary | Gait as measured by change in Tekscan measures of force | Tekscan records a standard set of measures of time and force. Change in peak force at loading response, mid-stance, and terminal stance in newtons. | through study completion (4 weeks) and one time follow-up at an average of 6 months | |
Secondary | Pulmonary function change measure by spirometry | Spirometry provides standard measures of respiratory volume and volume in time. Changes in Forced Vital Capacity and Forced Expiratory Volume in 1 second were the measures of interest. | through study completion (4 weeks) and one time follow-up at an average of 6 months | |
Secondary | Patient perception as measured by changes in Cognitive Mapping | Cognitive mapping provides the issues, concerns, and perceptions of the participants of how posture affects their life. Measured by words recorded and qualitative analysis. | through study completion (4 weeks) and one time follow-up at an average of 6 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT06000696 -
Healthy at Home Pilot
|
||
Active, not recruiting |
NCT03927820 -
A Pharmacist-Led Intervention to Increase Inhaler Access and Reduce Hospital Readmissions (PILLAR)
|
N/A | |
Completed |
NCT04043728 -
Addressing Psychological Risk Factors Underlying Smoking Persistence in COPD Patients: The Fresh Start Study
|
N/A | |
Completed |
NCT04105075 -
COPD in Obese Patients
|
||
Recruiting |
NCT05825261 -
Exploring Novel Biomarkers for Emphysema Detection
|
||
Active, not recruiting |
NCT04075331 -
Mepolizumab for COPD Hospital Eosinophilic Admissions Pragmatic Trial
|
Phase 2/Phase 3 | |
Terminated |
NCT03640260 -
Respiratory Regulation With Biofeedback in COPD
|
N/A | |
Recruiting |
NCT04872309 -
MUlti-nuclear MR Imaging Investigation of Respiratory Disease-associated CHanges in Lung Physiology
|
||
Recruiting |
NCT05145894 -
Differentiation of Asthma/COPD Exacerbation and Stable State Using Automated Lung Sound Analysis With LungPass Device
|
||
Withdrawn |
NCT04210050 -
Sleep Ventilation for Patients With Advanced Hypercapnic COPD
|
N/A | |
Terminated |
NCT03284203 -
Feasibility of At-Home Handheld Spirometry
|
N/A | |
Recruiting |
NCT06110403 -
Impact of Long-acting Bronchodilator- -Corticoid Inhaled Therapy on Ventilation, Lung Function and Breathlessness
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT06040424 -
Comparison of Ipratropium / Levosalbutamol Fixed Dose Combination and Ipratropium and Levosalbutamol Free Dose Combination in pMDI Form in Stable Chronic Obstructive Pulmonary Disease (COPD) Patients
|
Phase 3 | |
Recruiting |
NCT05865184 -
Evaluation of Home-based Sensor System to Detect Health Decompensation in Elderly Patients With History of CHF or COPD
|
||
Recruiting |
NCT04868357 -
Hypnosis for the Management of Anxiety and Breathlessness During a Pulmonary Rehabilitation Program
|
N/A | |
Completed |
NCT01892566 -
Using Mobile Health to Respond Early to Acute Exacerbations of COPD in HIV
|
N/A | |
Completed |
NCT04119856 -
Outgoing Lung Team - a Cross-sectorial Intervention in Patients With COPD
|
N/A | |
Completed |
NCT04485741 -
Strados System at Center of Excellence
|
||
Completed |
NCT03626519 -
Effects of Menthol on Dyspnoea in COPD Patients
|
N/A | |
Recruiting |
NCT04860375 -
Multidisciplinary Management of Severe COPD
|
N/A |